Inactive Instrument

Press Releases GenMark Diagnostics, Inc.

Stocks

GNMK

US3723091043

Advanced Medical Equipment & Technology

Press Releases

21-04-22	GENMARK DIAGNOSTICS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
21-03-19	SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of GenMark Diagnostics, Inc. - GNMK	PR
21-03-17	GENMARK INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of GenMark Diagnostics - GNMK	BU
21-03-15	GENMARK DIAGNOSTICS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
21-03-15	SHAREHOLDER ALERT: WeissLaw LLP Investigates GenMark Diagnostics, Inc.	PR
21-03-15	GenMark Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GenMark Diagnostics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – GNMK	BU
21-03-15	GENMARK DIAGNOSTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
21-02-25	GenMark Diagnostics: 4Q Earnings Snapshot	AQ
21-02-25	GENMARK DIAGNOSTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
21-02-25	GENMARK DIAGNOSTICS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	AQ
21-02-25	GenMark Diagnostics Reports Fourth Quarter and Full Year 2020 Results	GL
21-02-24	GENMARK DIAGNOSTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
21-02-22	GenMark ePlex® RP2 Panel Predicted to Detect Known SARS-CoV-2 Variants Currently in Circulation Based on in silico Analysis	GL
21-02-16	GenMark Diagnostics to Participate in the Cowen 41st Annual Health Care Conference	GL
21-02-16	Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels	GL
21-02-11	GenMark Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021	GL
21-01-12	GenMark Diagnostics : GNMK January 2021 Investor Presentation	PU
21-01-11	GENMARK DIAGNOSTICS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	AQ
21-01-11	GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2020	GL
20-12-28	GenMark Diagnostics to Participate in Upcoming Investor Conferences	GL
20-11-05	GenMark Diagnostics : to Participate in the Canaccord Virtual MedTech & Diagnostics Forum	AQ
20-11-05	GenMark Diagnostics to Participate in the Canaccord Virtual MedTech & Diagnostics Forum	GL
20-11-04	GenMark Diagnostics : GNMK November 2020 Investor Presentation	PU
20-10-28	GenMark Diagnostics: 3Q Earnings Snapshot	AQ
20-10-28	GENMARK DIAGNOSTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ